Last Updated: November 8, 2026

List of Excipients in API TOFACITINIB CITRATE

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing TOFACITINIB CITRATE

Company Ingredient NDC Excipient
Padagis US LLC tofacitinib citrate 0574-1811 AMMONIA
Padagis US LLC tofacitinib citrate 0574-1811 CELLULOSE ACETATE
Padagis US LLC tofacitinib citrate 0574-1811 COPOVIDONE K25-31
Padagis US LLC tofacitinib citrate 0574-1811 FERRIC OXIDE RED
Padagis US LLC tofacitinib citrate 0574-1811 FERRIC OXIDE YELLOW
Padagis US LLC tofacitinib citrate 0574-1811 FERROSOFERRIC OXIDE
Padagis US LLC tofacitinib citrate 0574-1811 HYDROXYETHYL CELLULOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for TOFACITINIB CITRATE

Excipient focus: AMMONIA

Excipient focus: CELLULOSE ACETATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

TOFACITINIB CITRATE drug variants containing MAGNESIUM STEARATE

Company Ingredient NDC
Padagis US LLC tofacitinib citrate 0574-1811
ScieGen Pharmaceuticals INC tofacitinib citrate 50228-567
Breckenridge Pharmaceutical Inc tofacitinib citrate 51991-329
Radha Pharmaceuticals Inc tofacitinib citrate 77771-567
Golden State Medical Supply Inc tofacitinib citrate 84677-081
Stellon Biotech Inc tofacitinib citrate 85972-121
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SORBITOL

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links